Italy
· Delayed Price · Currency is EUR BioMarin Pharmaceutical Statistics
Total Valuation
BIT:1BMRN has a market cap or net worth of EUR 9.98 billion. The enterprise value is 9.53 billion.
| Market Cap | 9.98B |
| Enterprise Value | 9.53B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 179.43M |
Valuation Ratios
The trailing PE ratio is 24.20.
| PE Ratio | 24.20 |
| Forward PE | n/a |
| PS Ratio | 3.62 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | 21.19 |
| P/OCF Ratio | 18.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.93, with an EV/FCF ratio of 20.25.
| EV / Earnings | 23.13 |
| EV / Sales | 3.80 |
| EV / EBITDA | 15.93 |
| EV / EBIT | 19.02 |
| EV / FCF | 20.25 |
Financial Position
The company has a current ratio of 5.33, with a Debt / Equity ratio of 0.11.
| Current Ratio | 5.33 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | 1.30 |
| Interest Coverage | 45.01 |
Financial Efficiency
Return on equity (ROE) is 8.05% and return on invested capital (ROIC) is 5.76%.
| Return on Equity (ROE) | 8.05% |
| Return on Assets (ROA) | 5.15% |
| Return on Invested Capital (ROIC) | 5.76% |
| Return on Capital Employed (ROCE) | 8.93% |
| Revenue Per Employee | 906,775 |
| Profits Per Employee | 135,626 |
| Employee Count | 3,040 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 0.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.16% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.16% |
| 50-Day Moving Average | 63.21 |
| 200-Day Moving Average | 67.22 |
| Relative Strength Index (RSI) | 5.39 |
| Average Volume (20 Days) | 15 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, BIT:1BMRN had revenue of EUR 2.76 billion and earned 412.30 million in profits. Earnings per share was 2.13.
| Revenue | 2.76B |
| Gross Profit | 2.20B |
| Operating Income | 550.60M |
| Pretax Income | 523.29M |
| Net Income | 412.30M |
| EBITDA | 643.74M |
| EBIT | 550.60M |
| Earnings Per Share (EPS) | 2.13 |
Balance Sheet
The company has 1.10 billion in cash and 612.35 million in debt, giving a net cash position of 486.56 million.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 612.35M |
| Net Cash | 486.56M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.47B |
| Book Value Per Share | 28.65 |
| Working Capital | 2.54B |
Cash Flow
In the last 12 months, operating cash flow was 553.31 million and capital expenditures -82.51 million, giving a free cash flow of 470.80 million.
| Operating Cash Flow | 553.31M |
| Capital Expenditures | -82.51M |
| Free Cash Flow | 470.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.67%, with operating and profit margins of 19.97% and 14.96%.
| Gross Margin | 79.67% |
| Operating Margin | 19.97% |
| Pretax Margin | 18.98% |
| Profit Margin | 14.96% |
| EBITDA Margin | 23.35% |
| EBIT Margin | 19.97% |
| FCF Margin | 17.08% |
Dividends & Yields
BIT:1BMRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | -2.67% |
| Earnings Yield | 4.13% |
| FCF Yield | 4.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1BMRN has an Altman Z-Score of 7.99.
| Altman Z-Score | 7.99 |
| Piotroski F-Score | n/a |